GlaxoSmithKline announced that Wellbutrin XR (bupropion hydrochloride modified-release tablets) has been granted a marketing license in The Netherlands for the treatment of adult patients with major depressive episodes.
From: www.pharmabiz.com
GSK gets European approval for Wellbutrin XR
Posted by Ruslan Abuzant at 8:42 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment